Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral interference and interferon

F Dianzani

    La Ricerca in Clinica E in Laboratorio
    |July 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Viral interference makes cells resistant to reinfection, primarily through interferon. This protein induces antiviral states, offering potential for new viral disease therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of the antiviral effect of new compounds by using cellular cultures.

    Cytotechnology·2012
    Same author

    Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients.

    Medical microbiology and immunology·2008
    Same author

    What is the practical significance of antibodies to interferons?

    BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
    Same author

    Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2006
    Same author

    Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.

    Cellular and molecular biology (Noisy-le-Grand, France)·2006
    Same author

    Key questions in antiretroviral therapy: Italian Consensus Workshop (2005).

    The Journal of antimicrobial chemotherapy·2006
    Same journal

    Increase of plasma tissue-plasminogen activator antigen levels after induced abortion.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Role of prostaglandin E2 on defective interferon-gamma production during type B acute viral hepatitis.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    The use of recombinant factor VIII in the management of hemophilia.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    The functioning liver mass.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Liver system. V. Activation-extinction line of cyclic hepatocyte activities.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Liver system. IV. More on the liver micro-unit: physics and geometry of its action.

    La Ricerca in clinica e in laboratorio·1991
    See all related articles

    Area of Science:

    • Virology
    • Immunology
    • Cell Biology

    Background:

    • Viral interference confers cellular resistance to superinfection.
    • Interferon, a protein produced by virus-infected cells, is the primary mediator of viral interference.
    • Interferon production is triggered by viral nucleic acids.

    Purpose of the Study:

    • To elucidate the mechanisms of viral interference and the role of interferon.
    • To explore the potential therapeutic applications of the interferon system in viral diseases.

    Main Methods:

    • The study reviews existing evidence on viral interference and interferon.
    • It discusses the induction of antiviral proteins by interferon.
    • It examines the effects of interferon on nonviral organisms, tumor cells, and immune responses.

    Related Experiment Videos

    Main Results:

    • Interferon induces antiviral proteins that alter cellular proteosynthesis, creating an antiviral state.
    • The interferon system exhibits broader effects, including on nonviral organisms, tumor cells, and immune responses.
    • Interferon can be activated by various non-viral substances and is produced by T-lymphocytes.

    Conclusions:

    • The interferon system plays a critical role in viral recovery and presents potential for prophylactic and therapeutic use.
    • Exogenous interferon administration and the use of interferon inducers show promising preliminary results.
    • Further research is needed to overcome challenges before widespread clinical application of the interferon system for viral diseases.